BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1000921)

  • 1. [Study of oral Pindolol on exercise tolerance in angina pectoris].
    Broustet JP; Dubecq M; Daubèze J; Emeriau JP; Bricaud H
    Coeur Med Interne; 1976; 15(1):97-106. PubMed ID: 1000921
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris].
    De Petra V; Di Michele R; Cecchetti E
    Minerva Cardioangiol; 1973 Sep; 21(9):619-24. PubMed ID: 4745004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 5. Pindolol and alprenolol in angina pectoris: a comparative clinical study.
    Frithz G; Nordgren L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):133-8. PubMed ID: 803426
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of intravenous and oral pindolol on exercise tolerance and electrocardiographic changes in angina pectoris.
    Storstein L
    J Cardiovasc Pharmacol; 1980; 2(6):739-50. PubMed ID: 6160324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
    Boakes AJ; Prichard BN
    Br J Pharmacol; 1973 Mar; 47(3):673P-674P. PubMed ID: 4147197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of coenzyme Q10 injections on exercise tolerance in patients with stable angina pectoris].
    Hiasa Y; Ishida T; Maeda T; Iwano K; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1983 Apr; 31(4):419-23. PubMed ID: 6867496
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of placebo on exercise response and nitroglycerin consumption.
    Hartman KE; Nordstrom LA; Gobel FL
    Minn Med; 1976 Dec; 59(12):839-43. PubMed ID: 826781
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
    Duner H; Pernow B
    Indian Heart J; 1972 Jun; 24():Suppl 1:180-2. PubMed ID: 4667014
    [No Abstract]   [Full Text] [Related]  

  • 16. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of the beta-adrenergic blocker LB-46 (Pindolol) in the treatment of angina poectoris].
    Faerchtein I; Roque AF; Kastansky I
    Arq Bras Cardiol; 1972 Aug; 25(4):299-305. PubMed ID: 4644466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of various psychotropic drugs on the tolerance of patients with angina pectoris to dynamic and isometric exercise].
    Volkov VS; Pozdniakov IuM; Trotsiuk VV; Vinogradov VF; Zin'kovskiĭ AK
    Klin Med (Mosk); 1983 Mar; 61(3):23-8. PubMed ID: 6855152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in cardiac dynamics in angina pectoris and action of propranolol and pindolol in the normal subject and in angina patients].
    Moniz De Bettencourt J; Pinto BG
    Ann Cardiol Angeiol (Paris); 1975 Oct; 24(5):453-60. PubMed ID: 1163987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.